Bryan Dechairo is the founder of Sherlock Biosciences. Sherlock Biosciences has raised $111M in total funding. Latest round: Series B.
Bryan Dechairo is the President, CEO, and Director at Sherlock Biosciences, an innovative biotech company focused on democratizing and decentralizing diagnostic testing. The company engineers biology to bring next-generation diagnostics to the point-of-need, utilizing CRISPR and synthetic biology for DNA and RNA detection. Sherlock Biosciences has raised a total of $111 million in funding. Prior to his current role, Bryan was Executive VP at Myriad Genetics and CSO and CMO at Assurex Health.
Full founder directory · Investor directory · Company funding database · Fundraising library